Functional and Targeted Lymph Node Imaging in Prostate Cancer: Current Status and Future Challenges.

Item

http://www.wikidata.org/entity/Q47829959

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Functional and Targeted Lymph ...... Status and Future Challenges.

@en

Functional and Targeted Lymph ...... Status and Future Challenges.

@nl

type

Item

label

Functional and Targeted Lymph ...... Status and Future Challenges.

@en

Functional and Targeted Lymph ...... Status and Future Challenges.

@nl

prefLabel

Functional and Targeted Lymph ...... Status and Future Challenges.

@en

Functional and Targeted Lymph ...... Status and Future Challenges.

@nl

P1476

Functional and Targeted Lymph ...... Status and Future Challenges.

@en

P2093

Baris Turkbey

http://www.w3.org/2001/XMLSchema#string

Harriet C Thoeny

http://www.w3.org/2001/XMLSchema#string

Johannes M Froehlich

http://www.w3.org/2001/XMLSchema#string

Peter L Choyke

http://www.w3.org/2001/XMLSchema#string

Sebastiano Barbieri

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients.

Impact of fusion of indium-111 capromab pendetide volume data sets with those from MRI or CT in patients with recurrent prostate cancer.

PET/CT with (11)C-choline for evaluation of prostate cancer patients with biochemical recurrence: meta-analysis and critical review of available data.

Safety and tolerability of ultrasmall superparamagnetic iron oxide contrast agent: comprehensive analysis of a clinical development program.

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer.

Staging of prostate cancer.

The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.

Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer

Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005

Utility of a new bolus-injectable nanoparticle for clinical cancer staging.

P304

728-743

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1148/RADIOL.2017161517

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

285

http://www.w3.org/2001/XMLSchema#string

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29155624

http://www.w3.org/2001/XMLSchema#string

P921

lymph node

P932

5708287

http://www.w3.org/2001/XMLSchema#string